Synlogic (SYBX) Competitors $1.38 -0.03 (-1.77%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$1.40 +0.01 (+1.08%) As of 02/21/2025 04:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends SYBX vs. AADI, STTK, CTMX, VHAQ, CNTX, QNCX, KRON, UNCY, ONCY, and IOBTShould you be buying Synlogic stock or one of its competitors? The main competitors of Synlogic include Aadi Bioscience (AADI), Shattuck Labs (STTK), CytomX Therapeutics (CTMX), Viveon Health Acquisition (VHAQ), Context Therapeutics (CNTX), Quince Therapeutics (QNCX), Kronos Bio (KRON), Unicycive Therapeutics (UNCY), Oncolytics Biotech (ONCY), and IO Biotech (IOBT). These companies are all part of the "pharmaceutical products" industry. Synlogic vs. Aadi Bioscience Shattuck Labs CytomX Therapeutics Viveon Health Acquisition Context Therapeutics Quince Therapeutics Kronos Bio Unicycive Therapeutics Oncolytics Biotech IO Biotech Synlogic (NASDAQ:SYBX) and Aadi Bioscience (NASDAQ:AADI) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, media sentiment, earnings, analyst recommendations, institutional ownership, risk, community ranking and valuation. Does the media favor SYBX or AADI? In the previous week, Aadi Bioscience had 3 more articles in the media than Synlogic. MarketBeat recorded 3 mentions for Aadi Bioscience and 0 mentions for Synlogic. Synlogic's average media sentiment score of 0.00 equaled Aadi Bioscience'saverage media sentiment score. Company Overall Sentiment Synlogic Neutral Aadi Bioscience Neutral Do analysts recommend SYBX or AADI? Aadi Bioscience has a consensus price target of $1.67, suggesting a potential downside of 40.26%. Given Aadi Bioscience's higher possible upside, analysts clearly believe Aadi Bioscience is more favorable than Synlogic.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Synlogic 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Aadi Bioscience 0 Sell rating(s) 5 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has better valuation & earnings, SYBX or AADI? Synlogic has higher earnings, but lower revenue than Aadi Bioscience. Aadi Bioscience is trading at a lower price-to-earnings ratio than Synlogic, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSynlogic$3.37M4.81-$57.28M-$4.16-0.33Aadi Bioscience$24.35M2.83-$65.76M-$2.28-1.22 Do institutionals & insiders hold more shares of SYBX or AADI? 63.4% of Synlogic shares are held by institutional investors. Comparatively, 52.1% of Aadi Bioscience shares are held by institutional investors. 3.0% of Synlogic shares are held by insiders. Comparatively, 37.3% of Aadi Bioscience shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Is SYBX or AADI more profitable? Synlogic has a net margin of 0.00% compared to Aadi Bioscience's net margin of -246.06%. Aadi Bioscience's return on equity of -71.87% beat Synlogic's return on equity.Company Net Margins Return on Equity Return on Assets SynlogicN/A -207.84% -114.81% Aadi Bioscience -246.06%-71.87%-57.28% Which has more volatility and risk, SYBX or AADI? Synlogic has a beta of 0.81, suggesting that its stock price is 19% less volatile than the S&P 500. Comparatively, Aadi Bioscience has a beta of 0.64, suggesting that its stock price is 36% less volatile than the S&P 500. Does the MarketBeat Community believe in SYBX or AADI? Synlogic received 320 more outperform votes than Aadi Bioscience when rated by MarketBeat users. Likewise, 69.54% of users gave Synlogic an outperform vote while only 39.29% of users gave Aadi Bioscience an outperform vote. CompanyUnderperformOutperformSynlogicOutperform Votes33169.54% Underperform Votes14530.46% Aadi BioscienceOutperform Votes1139.29% Underperform Votes1760.71% SummarySynlogic beats Aadi Bioscience on 8 of the 15 factors compared between the two stocks. Get Synlogic News Delivered to You Automatically Sign up to receive the latest news and ratings for SYBX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SYBX vs. The Competition Export to ExcelMetricSynlogicPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$16.20M$7.04B$5.77B$8.98BDividend YieldN/A2.87%4.78%3.85%P/E Ratio-0.336.1326.4618.82Price / Sales4.81309.83453.2580.30Price / CashN/A67.8344.0437.47Price / Book0.306.747.634.64Net Income-$57.28M$138.11M$3.18B$245.69M7 Day Performance-1.07%-2.43%-1.91%-2.66%1 Month Performance-3.15%-1.91%-0.19%-2.15%1 Year Performance-28.97%-5.03%16.70%12.90% Synlogic Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SYBXSynlogicN/A$1.39-1.8%N/A-29.7%$16.20M$3.37M-0.3380AADIAadi Bioscience0.7882 of 5 stars$2.59-0.8%$1.67-35.6%+49.2%$63.97M$25.07M-1.1440STTKShattuck Labs3.5411 of 5 stars$1.33+6.4%$8.67+551.6%-84.4%$63.49M$1.66M-0.87100News CoverageCTMXCytomX Therapeutics4.3403 of 5 stars$0.80-3.6%$5.77+624.9%-46.2%$62.32M$101.21M4.68170Positive NewsVHAQViveon Health AcquisitionN/A$11.00flatN/A+1.8%$62.26MN/A0.002High Trading VolumeCNTXContext Therapeutics1.2627 of 5 stars$0.82+1.9%$6.33+670.9%-32.6%$61.62MN/A-0.907News CoverageGap UpQNCXQuince Therapeutics2.1336 of 5 stars$1.40-1.4%$9.50+578.6%+4.5%$61.60MN/A-1.1360KRONKronos Bio3.4407 of 5 stars$1.02flat$1.63+59.3%-5.0%$61.55M$6.29M-0.71100Positive NewsUNCYUnicycive Therapeutics3.0839 of 5 stars$0.59+5.7%$5.33+800.7%-62.4%$61.46M$680,000.00-0.619News CoverageONCYOncolytics Biotech1.6613 of 5 stars$0.77-0.6%$4.00+421.4%-28.9%$61.39MN/A-2.8430IOBTIO Biotech3.648 of 5 stars$0.93-0.9%$9.33+902.4%-28.1%$61.34MN/A-0.6830News CoveragePositive News Related Companies and Tools Related Companies Aadi Bioscience Competitors Shattuck Labs Competitors CytomX Therapeutics Competitors Viveon Health Acquisition Competitors Context Therapeutics Competitors Quince Therapeutics Competitors Kronos Bio Competitors Unicycive Therapeutics Competitors Oncolytics Biotech Competitors IO Biotech Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SYBX) was last updated on 2/22/2025 by MarketBeat.com Staff From Our Partners[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Synlogic, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Synlogic With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SYBX Stock Alerts